While these trends varied slightly among the six countries investigated, an overall trend of decreasing intention to use LA-PrEP with decreasing affordability was evident in all countries.
← all excerpts
The unseen impact of affordability: copayment sensitivity for long-acting PrEP among MSM in six European Countries, October 2023-April 2024.
1
—
—